ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Case Report

A 13 year-old boy with post-transplantation lymphoproliferative disorder presenting with obscure gastrointestinal bleeding: a case report

[version 1; peer review: 2 approved]
PUBLISHED 07 Apr 2014
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

One well recognized and potentially serious complication of chronic immunosuppression in organ transplant recipients is post-transplantation lymphoproliferative disorders (PTLD). This accounts for 20% of all malignancies in transplant recipients, which is four times higher than the general population1,2. The diagnosis of PTLD is often difficult, due to various manifestations resulting in late diagnosis. We report an unusual presentation of PTLD in a pediatric patient where the diagnosis was achieved only after extensive investigation.

Case presentation

This case involves a 13 year-old Caucasian boy with a history of cystic fibrosis status post deceased donor EnBloc combined liver and pancreas transplantation, presenting with gastrointestinal bleeding. His immune suppression regimen after the transplant included tacrolimus 1.5 mg twice daily.

Two years after his transplant, the patient presented to the hospital with “a few days of dark tarry stool”. He did not complain of any nausea, vomiting, or abdominal pain. He denied taking any anti-platelet agents or non-steroidal inflammatory drugs. On admission, the patient was hypotensive with a blood pressure of 70/50 mmHg and tachycardic with a heart rate of 112 beats per minute. His hemoglobin was 7.4 g/dL, which represented a drop from a baseline hemoglobin of 10 g/dL. After fluid resuscitation, the patient was started on pantoprazole continuous infusion at 5 mg/hour and sulcrafate suspension 300 mg four times daily. He then underwent an urgent upper endoscopy, which revealed multiple small prepyloric and duodenal ulcerations without signs of recent hemorrhage. Biopsies of these ulcers showed acute inflammation. A capsule endoscopy was then performed, which showed scattered duodenal erosions and two adjacent erosions in the distal duodenum without stigmata of recent bleeding. During the work-up, the patient continued to have melena, necessitating transfusions every three days. This prompted a second upper endoscopy, which showed complete healing of the prior ulcers. Interestingly, portal hypertensive gastropathy and a gastric varix were also noted. To target bleeding lesions potentially related to portal hypertension, octreotide continuous infusion at 2 mcg/kg/hour was initiated. Unfortunately, his melena persisted. The patient underwent a technetium-labeled red blood cell bleeding scan, where a potential bleeding source “near the anastomosis of the native to transplanted duodenum or proximal jejunum” was identified. A visceral arteriogram was obtained but it failed to detect a bleeding source. Following these radiological tests, a deep enteroscopy was performed. No signs of recent bleed within the suspected proximal hepatic limb of the Roux were detected. In the jejunum, however, there was a 10 mm clean-base, friable ulcer with significant oozing when it was biopsied. The pathological diagnosis of the ulcer was reported as follows: “the morphologic and immunophenotypic features indicate involvement of this patient’s jejunum of a large B-cell lymphoproliferative disorder consistent with diffuse large B-cell lymphoma (DLBCL). These findings thus support the diagnosis of a post-transplantation lymphoid disorder, involving small intestinal mucosa”. Epstein-Barr virus (EBV) was positive in the biopsied sample (See Figure 1).

59cfe44f-286f-45ea-8381-c4deb81fd99f_figure1.gif

Figure 1. Biopsy of jejunal ulcer.

1A: Haematoxylin & Eosin stain, 1000x. Large, centroblastic lymphoid cells with hyperchromatic, pleomorphic nuclei and moderate cytoplasm. These tumor cells almost completely efface the jejunal mucosa. Scattered mitotic activity and apopotic debris are present as well. 1B: Immunohistochemical stain for CD20, 1000x. Diffusely positive membranous staining in the tumor cells is indicative of lymphoid differentiation. In the context of the morphology seen in Figure 1A, the findings are compatible with a Diffuse Large B-Cell Lymphoma (DLBCL). Per the 2008 World Health Organization (WHO) classification, a lymphoid proliferation that meets the criteria for a high grade malignancy (in this case DLBCL) that occurs in a recipient of a solid organ, bone marrow, or stem cell transplant is diagnostic of a post-transplant lymphoproliferative disorder (PTLD). 1C: In situ hybridization for Epstein-Barr virus encoded RNA (EBER), 1000x. Strong nuclear positivity is seen in the majority of the tumor cells, a finding seen in many monomorphic PTLD cases.

Follow-up and outcome

An abdominal MRI performed a few days later demonstrated a mild thickening of the segments of small bowel in the left upper quadrant and portal hypertension. No lymphadenopathy was found in the abdomen and pelvis. The patient was then evaluated by the pediatric oncology service. A bone marrow biopsy reassuringly showed a normocellular marrow. The patient was started on cyclophosphamide, rituximab, and prednisone. His gastrointestinal bleeding eventually stopped a few weeks later.

Discussion

PTLD are rare but potentially fatal complications of solid organ transplantation3. The overall incidence of lymphoproliferative disorders in the transplant population is approximately 1% at 10 years, which is significantly higher than the general population3. The risk increases with the intensity of induction or rescue immunosuppression, and particularly following monoclonal or polyclonal anti-lymphocyte therapy46. The EBV serostatus of the recipient is another risk factor7, although PTLD can occur in EBV-negative diseases as well. Time post-transplant is also a key factor as the majority of PTLD occurs within the first year post-transplant8. Over half of the patients with PTLD present with extranodal masses9. PTLD can affect many organs, including the gastrointestinal tract, lungs, liver, central nervous system, and the allograft itself. Clinical manifestations vary, ranging from benign polyclonal lymphoproliferation (infectious mononucleosis-type acute illness) to aggressive and disseminated malignant disease. Gastrointestinal features typically include abdominal pain, fever, and bowel perforation in serious cases. There have been case reports describing gastrointestinal bleeding as the initial presentation of PTLD in the pediatric population1013, but this is less common. This case highlights the importance of considering the diagnosis of post-transplantation lymphoproliferative disorders in transplant receipts presenting with unexplained gastrointestinal hemorrhage.

Consent

Informed consent for publication of clinical details and clinical images was obtained from the next of kin.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 07 Apr 2014
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Ho EY, George V, McCracken M and Ostroff JW. A 13 year-old boy with post-transplantation lymphoproliferative disorder presenting with obscure gastrointestinal bleeding: a case report [version 1; peer review: 2 approved]. F1000Research 2014, 3:88 (https://doi.org/10.12688/f1000research.3252.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 07 Apr 2014
Views
6
Cite
Reviewer Report 04 Aug 2014
David Teachey, Department of Pediatric Hematology and Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA 
Approved
VIEWS 6
This is an interesting case report that emphasizes the need to consider the diagnosis of PTLD in post-transplant recipients who present with GI bleeding. It is a well-written report but could be improved by additional details.
 
  1. Readers could benefit from a
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Teachey D. Reviewer Report For: A 13 year-old boy with post-transplantation lymphoproliferative disorder presenting with obscure gastrointestinal bleeding: a case report [version 1; peer review: 2 approved]. F1000Research 2014, 3:88 (https://doi.org/10.5256/f1000research.3492.r4390)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
10
Cite
Reviewer Report 07 May 2014
Patrizia Comoli, Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy 
Approved
VIEWS 10
This is an interesting case that highlights the importance of considering PTLD in the differential diagnosis of gastrointestinal bleeding occurring after transplantation. The case report is well written, but requires a few minor revisions.

Article content
  • A few clinical details, important for the
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Comoli P. Reviewer Report For: A 13 year-old boy with post-transplantation lymphoproliferative disorder presenting with obscure gastrointestinal bleeding: a case report [version 1; peer review: 2 approved]. F1000Research 2014, 3:88 (https://doi.org/10.5256/f1000research.3492.r4391)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 07 Apr 2014
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.